Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3159401000168115 | Abilify Maintena (aripiprazole 400 mg + inert substance) modified release injection, 1 syringe (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3159411000168117 | Abilify Maintena (aripiprazole 400 mg + inert substance) modified release injection, 1 syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Abilify Maintena (aripiprazole 400 mg + inert substance) modified release injection, 1 syringe | Is a | aripiprazole 400 mg + inert substance modified release injection, 1 syringe | false | Inferred relationship | Some | ||
| Abilify Maintena (aripiprazole 400 mg + inert substance) modified release injection, 1 syringe | Is a | trade product pack | false | Inferred relationship | Some | ||
| Abilify Maintena (aripiprazole 400 mg + inert substance) modified release injection, 1 syringe | has TPUU | Abilify Maintena (aripiprazole 400 mg + inert substance) modified release injection, syringe | false | Inferred relationship | Some | ||
| Abilify Maintena (aripiprazole 400 mg + inert substance) modified release injection, 1 syringe | has TP | Abilify Maintena | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Abilify Maintena (aripiprazole 400 mg + inert substance) modified release injection, 1 syringe, dual chamber syringe | Is a | False | Abilify Maintena (aripiprazole 400 mg + inert substance) modified release injection, 1 syringe | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set
FHIR